Figure S3 from Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin Plus Docetaxel
Priyanka Sharma, Sara López‐Tarruella,José Ángel García Saenz,Qamar J. Khan,Henry Gómez, Aleix Prat,Fernando Moreno, Yolanda Jerez-Gilarranz,Agustí Barnadas,Antoni C. Picornell,María del Monte‐Millán,Milagros González‐Rivera,Tatiana Massarrah,Beatriz Peláez-Lorenzo,María Isabel Palomero,Ricardo González del Val,Javier Cortés,Hugo Fuentes,Denisse Bretel Morales, Iván Marquez‐Rodas,Charles M. Perou,Carolyn Lehn,Yen Y. Wang,Jennifer R. Klemp, Joshua V. Mammen,Jamie L. Wagner,Amanda L. Amin,Anne O’Dea,Jaimie Heldstab, Roy A. Jensen, Bruce F. Kimler,Andrew K. Godwin,Miguel Martín openalex
摘要
Recurrence-free survival and overall survival by adjuvant chemotherapy use in RCB II/III patients
更多查看译文
关键词
Neoadjuvant Therapy,Treatment Response,Survival Analysis
AI 理解论文
溯源树
样例
